• Study on Pembrolizumab for Patients with Localized Non-Metastatic MSI/dMMR Tumors or EBV+ Gastric Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study of platinum, pemetrexed, atezolizumab and bevacizumab combination in patients with advanced non-small cell lung cancer who have EGFR, ALK or ROS1 mutations and progressed after targeted therapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    France
  • Study of three different doses of busulfan with fludarabine and thymoglobuline in stem cell transplantation for patients with high-risk myeloid blood disorders

    Not recruiting

    2 1 1 1
    France
  • Study on Ivabradine for Preventing Heart Injury in Patients with Atherosclerosis Undergoing Noncardiac Surgery

    Not recruiting

    3 1 1
    Investigated Drugs:
    Poland
  • Study of prednisone and azathioprine treatment in patients with virus-negative myocarditis or inflammatory heart muscle disease with reduced heart pump function

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland
  • Study on Hydrocortisone and Fludrocortisone for Adults with Critical Illness-Related Corticosteroid Insufficiency

    Not recruiting

    3 1 1
    Investigated Diseases:
    France
  • Study on Inhaled Seralutinib (GB002) for Patients with Pulmonary Arterial Hypertension (PAH)

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia Germany Spain
  • Study on WT1 LAMP mRNA DC and Temozolomide for Patients with Newly Diagnosed Glioblastoma

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium
  • Study on Allergy to Phleum pratense and Dactylis glomerata: Testing Reactions to Phleum pratense and Dactylis glomerata Pollen Extracts in Patients with Allergies

    Not recruiting

    2 1 1
    Spain
  • Study on the Effects of Riociguat and Macitentan in Patients with Inoperable Chronic Thromboembolic Pulmonary Hypertension

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

powered by